ISABEL MUNOZ: Open Payments
NPI 1427218809 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 34 payments from 14 companies in 2025. Trend: 2023 $353 · 2024 $812 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $122 |
| SANOFI-AVENTIS U.S. LLC | 5 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $101 |
| Exact Sciences Corporation | 2 | $68 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Novo Nordisk Inc | 3 | $54 |
| Amgen Inc. | 3 | $44 |
| RGH Enterprises LLC | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| ACADIA Pharmaceuticals Inc | 2 | $37 |
Products named: XIFAXAN, TZIELD, JARDIANCE, Cologuard Collection Kit, BREZTRI, Rybelsus, Kerendia, DAYBUE.
Industry payments across TX — which companies pay providers there.
